fda announcement tirzepatide What is the latest update on the Compounded ban FDA sets tirzepatide compounding deadlines

Among research peptides, ARA-290 occupies a distinctive position: it has more human clinical trial data than most compounds in the peptide space, including Phase 2 randomized controlled trials for sarcoidosis-associated small fiber neuropathy and diabetic neuropathy, and it holds both FDA Orphan Drug and Fast Track designations for neuropathic pain in sarcoidosis

The lyophilized cake tolerates short ambient shipping windows because all three peptides are stable in the dry state, but the vial should be transferred to refrigeration immediately on arrival

Chen, G., Liang, G., Ou, J., Goldstein, J

How is that possible